Rheumatoid arthritis (RA) has a negative impact on bone that is partly mediated by anti-
citrullinated proteins antibodies (ACPA). These antibodies are associated with erosions, and …

Since the previous studies showed that anti-citrullinated protein antibodies (ACPA) can
induce osteoclasts differentiation and activation, even before arthritis onset, the aim of our …

Background Anti-citrullinated protein antibodies (ACPA) have been suggested to have a
potential role in both bone loss and pain in rheumatoid arthritis (RA), based on studies in …

A large fraction of the patients with rheumatoid arthritis (RA) develop specific autoantibodies,
which until recently were only of two types, rheumatoid factor (RF) and anti-citrullinated …

Objective Autoantibodies, such as anti–citrullinated protein antibodies (ACPAs), have been
described as inducing bone loss in rheumatoid arthritis (RA), which can also be reflected by …

Background Autoantibodies such as anti-citrullinated protein antibodies (ACPA) are major
risk factors for articular bone destruction from the earliest phases of rheumatoid arthritis …

Bone loss in rheumatoid arthritis (RA) is a key feature both local and systemic. Anti-
citrullinated protein antibodies (ACPA) have recently been found to directly induce …

Objectives Anti-carbamylated protein antibodies (anti-CarP Abs) are present in patients with
RA, however, their association with bone loss is not confirmed. The purpose of this study …

Background We investigated the association of serum anti-carbamylated protein (anti-CarP)
antibodies with disease activity and bone loss in rheumatoid arthritis (RA). Methods The …

Anti-carbamylated protein (anti-CarP) antibodies are promising biomarkers in rheumatoid
arthritis (RA), although their significance in seronegative disease (SNRA) remains uncertain …